NCT03180736 2025-12-19EMN14European Myeloma Network B.V.Phase 3 Completed304 enrolled 19 charts 1 FDA
NCT02541383 2025-04-13CassiopeiaIntergroupe Francophone du MyelomePhase 3 Completed1,085 enrolled 22 charts 1 FDA
NCT02784171 2024-12-10Pembrolizumab in Patients With Advanced Malignant Pleural MesotheliomaCanadian Cancer Trials GroupPhase 2/3 Completed520 enrolled 16 charts 1 FDA
NCT00372593 2021-03-24Combination Chemotherapy With or Without Gemtuzumab in Treating Young Patients With Newly Diagnosed Acute Myeloid LeukemiaChildren's Oncology GroupPhase 3 Completed1,070 enrolled 18 charts 2 FDA
NCT00939770 2020-06-09Crizotinib in Treating Younger Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell LymphomaChildren's Oncology GroupPhase 1/2 Completed122 enrolled 24 charts 2 FDA